Canlyniadau Chwilio - Buch, Maya

Treating rheumatoid arthritis with tumour necrosis factor α blockade: May be a giant therapeutic leap or a small expensive step gan Emery, Paul, Buch, Maya

Cael y testun llawn Cael y testun llawn

The ‘therapeutic window’ and treating to target in rheumatoid arthritis gan Hunt, Laura, Buch, Maya

Cael y testun llawn Cael y testun llawn Cael y testun llawn

'Difficult to treat' rheumatoid arthritis: current position and considerations for next steps gan Tan, Yvonne, Buch, Maya H

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Efficacy, tolerability and safety of biologic therapy in rheumatoid disease: patient considerations gan Horton, Sarah, Buch, Maya H, Emery, Paul

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Abatacept in the treatment of rheumatoid arthritis gan Buch, Maya H, Vital, Edward M, Emery, Paul

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified Therapy gan Ouboussad, Lylia, Burska, Agata N., Melville, Andrew, Buch, Maya H.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis? gan Romão, Vasco C., Vital, Edward M., Fonseca, João Eurico, Buch, Maya H.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Unmet foot health needs in people with Systemic Sclerosis: an audit of foot health care provision gan Alcacer-Pitarch, Begonya, Siddle, Heidi, Christie, Mathew, Buch, Maya, Emery, Paul, Redmon, Anthony

Cael y testun llawn Cael y testun llawn

Absence of Scleroderma pattern at nail fold capillaroscopy valuable in the exclusion of Scleroderma in unselected patients with Raynaud’s Phenomenon gan Bissell, Lesley-Anne, Abignano, Giuseppina, Emery, Paul, Del Galdo, Francesco, Buch, Maya H.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Syndemics & syndemogenesis in COVID-19 and rheumatic and musculoskeletal diseases: old challenges, new era gan Nikiphorou, Elena, Alpizar-Rodriguez, Deshire, Gastelum-Strozzi, Alfonso, Buch, Maya, Peláez-Ballestas, Ingris

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The perpetual sword of Damocles: Cardiac involvement in systemic sclerosis and the role of non-invasive imaging modalities in medical decision making gan Mavrogeni, Sophie I., Buch, Maya, Markousis-Mavrogenis, George, Dumitru, Bianca, Pugliese, Nicola Riccardo, Gargani, Luna

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Single-centre experience of refractory rheumatoid arthritis gan Fitton, John, Melville, Andrew, Naraghi, Kamran, Nam, Jacqueline, Dass, Shouvik, Emery, Paul, Buch, Maya H

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR rec... gan Gaujoux-Viala, Cécile, Nam, Jackie, Ramiro, Sofia, Landewé, Robert, Buch, Maya H, Smolen, Josef S, Gossec, Laure

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Coronary Artery Disease Evaluation in Rheumatoid Arthritis (CADERA): study protocol for a randomized controlled trial gan Erhayiem, Bara, Pavitt, Sue, Baxter, Paul, Andrews, Jacqueline, Greenwood, John P, Buch, Maya H, Plein, Sven

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Mixed results with baricitinib in biological-resistant adult-onset Still’s disease and undifferentiated systemic autoinflammatory disease gan Kacar, Mark, Fitton, John, Gough, Andrew K, Buch, Maya H, McGonagle, Dennis G, Savic, Sinisa

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Ultrasound-detectable grey scale synovitis predicts future fulfilment of the 2010 ACR/EULAR RA classification criteria in patients with new-onset undifferentiated arthritis gan Horton, Sarah C, Tan, Ai Lyn, Wakefield, Richard J, Freeston, Jane E, Buch, Maya H, Emery, Paul

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Changes in the pharmacological management of rheumatoid arthritis over two decades gan Crossfield, Samantha S R, Buch, Maya H, Baxter, Paul, Kingsbury, Sarah R, Pujades-Rodriguez, Mar, Conaghan, Philip G

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study gan Galloway, James, Barrett, Kevin, Irving, Peter, Khavandi, Kaivan, Nijher, Monica, Nicholson, Ruth, de Lusignan, Simon, Buch, Maya H

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Muscle deterioration due to rheumatoid arthritis: assessment by quantitative MRI and strength testing gan Farrow, Matthew, Biglands, John, Tanner, Steven, Hensor, Elizabeth M A, Buch, Maya H, Emery, Paul, Tan, Ai Lyn

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Cardiac magnetic resonance imaging for the detection of myocardial involvement in granulomatosis with polyangiitis gan Giollo, Alessandro, Dumitru, Raluca B., Swoboda, Peter P., Plein, Sven, Greenwood, John P., Buch, Maya H., Andrews, Jacqueline

Cael y testun llawn Cael y testun llawn Cael y testun llawn